SCHEMBL3343397

SCHEMBL3343397

Cc1cc(-c2ccc(N)c(Cl)c2)nn1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.48
ALDH1A1 P00352 4/20 0.48
TSHR P16473 3/20 0.48
MAPK1 P28482 1/20 0.48
ESR2 Q92731 1/20 0.42
KMT2A Q03164 4/20 0.38
KMO O15229 3/20 0.37
MAPT P10636 4/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
MEN1 O00255 3/20 0.35
TP53 P04637 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156152 0.83 ALDH1A1 (0.53) CYP3A4ALDH1A1TSHRKMT2AMAPT
SCHEMBL3342123 0.80 RAB9A (0.42) CYP3A4ALDH1A1TSHRKMT2AMAPT
SCHEMBL20150182 0.78 AAK1 (0.35) CYP3A4ALDH1A1TSHRKMT2AMAPT
SCHEMBL20092476 0.78 ALDH1A1 (0.56) CYP3A4ALDH1A1TSHRMAPK1KMT2A
SCHEMBL3343394 0.78 MKNK1 (0.47) KMT2AMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL14091695 0.78 NPC1 (0.54) ALDH1A1TSHRKMT2AMAPTNPC1
SCHEMBL12491752 0.77 KEAP1 (0.58) CYP3A4ALDH1A1TSHRMAPK1ESR2
SCHEMBL23154025 0.76 GAA (0.33) CYP3A4ALDH1A1TSHRKMT2AMAPT
SCHEMBL20092249 0.76 TYK2 (0.43) MAPTGAA
SCHEMBL23329066 0.75 TMEM97 (0.44) CYP3A4ALDH1A1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CYP3A4 1590/4885ALDH1A1 1506/4885TSHR 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.